Caroline Elizabeth Haggerty Bresnan is a Lakeland, Florida based female rheumatologist who is specialized in Rheumatology. Active license number of Caroline Elizabeth Haggerty Bresnan for Rheumatology is ME167695 in Florida. Caroline Elizabeth Haggerty Bresnan treat joint disease similar to orthopedists but do not perform surgeries. She diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Caroline Elizabeth Haggerty Bresnan speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Gender:
Female
Practice Address:
3030 Harden Blvd, Lakeland, Florida, 33803-7952
Phone:
863-687-1100
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1689135907
NPI Enumeration Date:
28 Mar, 2019
NPI Last Update On:
16 Sep, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Caroline Elizabeth Haggerty Bresnan are as mentioned below.
License Number
Specialization
State
Status
ME167695
Rheumatologist
Florida
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
17 Davis Blvd Ste 308, Tampa, Florida
Zip:
33606-3438
Phone Number:
--
Fax Number:
--
Patients can reach Caroline Elizabeth Haggerty Bresnan at 3030 Harden Blvd, Lakeland, Florida or can call to book an appointment on 863-687-1100. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.